Sort
261,768 grants matching “gene therapy”
Pharmacogenomics of Anti-platelet Agents for CVD Prevention
$1,450,524Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2007 · GM
Functional genomic screens for molecular targets in cancer
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Clinical development of mechanism-based lymphoma therapies
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,450,380Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Role of Transforming Growth Factor Beta (TGFbeta) in Promoting Allergic Inflammation
$1,450,350Pamela Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Protein Phosphorylation and Regulation of cytoskeleton in Neuronal System Physiology and Pathology
$1,450,279Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Antisense Oligonucleotide (ASO) Development for Rare and Neglected Diseases
$1,450,000Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
DCTD Biopharmaceutical Development - Type 1 Diabetes RAID projects
$1,450,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)
$1,449,910Daniel Chelsky · Circumvent Pharmaceuticals, Inc. · R44 · FY2022 · NS
The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients
$1,449,598Levi Alexander Garraway · Dana-Farber Cancer Inst · U01 · FY2013 · HG
Customized stem cells for clinical application in blood disorders
$1,449,467George Q Daley · Boston Children'S Hospital · R24 · FY2014 · DK
Longitudinal Assessment of Manic Symptoms
$1,449,459Robert L Findling · Case Western Reserve University · R01 · FY2011 · MH
BREAD: Basic Mechanisms Underlying Species-Specific Trypanosome Resistance
$1,449,451Jayne Raper · New York University Medical Center · · FY2010 · BIO
Studies of Hereditary Neurological Disease: Disease Mechanisms
$1,449,410Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
India International Center for Excellence in Research
$1,449,342Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Molecular Tracer and Imaging Core Facility
$1,449,227Dale O Kiesewetter · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2018 · EB
Center for Molecular Imaging Research at MGH/HMS
$1,449,218Ralph Weissleder · Massachusetts General Hospital · P50 · FY2013 · CA
Investigation of viral and host determinants of gammaherpesvirus pathogenesis
$1,449,199Laurie T Krug · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
UCLA SPORE in Prostate Cancer
$1,449,094Robert E Reiter · University Of California Los Angeles · P50 · FY2020 · CA
Center for Adaptive Treatment of Cigarette Addiction
$1,448,439Jed E Rose · Duke University · P50 · FY2014 · DA
DNA Repair in Human Cancer-Prone Genetic Diseases
$1,448,400Kenneth H Kraemer · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SBIR Phase II: An Automated Platform for Rapid Discovery in Cell Biology
$1,448,152Michael Chiu · Kytopen Corp · · FY2019 · TIP
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
$1,447,782Linda C Giudice · University Of California, San Francisco · P01 · FY2021 · HD
The Role of Sirt6 in Acrolein-Induced Ocular Injury
$1,447,549Hua Liu · University Of Texas Med Br Galveston · R01 · FY2025 · EY